Cargando…
Biologic monotherapy in the biologic naïve patient with rheumatoid arthritis (RA): results from an observational study
Approximately one-third of patients on biologic therapy for rheumatoid arthritis (RA) receive them as monotherapy. There are few head-to-head randomised control trials comparing biologics as monotherapy. Our aim was to compare the efficacy and persistence of multimodal biologic agents as monotherapy...
Autores principales: | Benson, Rosalind, Zhao, Sizheng Steven, Goodson, Nicola, Abernethy, Rikki, Mewar, Devesh, Barnes, Theresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256103/ https://www.ncbi.nlm.nih.gov/pubmed/32086605 http://dx.doi.org/10.1007/s00296-020-04531-6 |
Ejemplares similares
-
Large joints are progressively involved in rheumatoid arthritis irrespective of rheumatoid factor status—results from the early rheumatoid arthritis study
por: Zhao, Sizheng Steven, et al.
Publicado: (2021) -
Biologic monotherapy in the treatment of rheumatoid arthritis
por: Detert, Jacqueline, et al.
Publicado: (2015) -
Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data
por: Pappas, Dimitrios A., et al.
Publicado: (2020) -
Characteristics Associated with Biologic Monotherapy Use in Biologic-Naive Patients with Rheumatoid Arthritis in a US Registry Population
por: Pappas, Dimitrios A., et al.
Publicado: (2015) -
Lysozyme and its biological value in rheumatoid arthritis (RA)
por: Smirnow, J, et al.
Publicado: (2001)